GLP-1 period changes: why your cycle may shift on Ozempic, Mounjaro or Zepbound
US labels for Ozempic, Wegovy, Mounjaro and Zepbound don't list period changes as a side effect, but weight loss can shift cycles, and FDA safety reports include heavy and irregular bleeding. A late period can also mean pregnancy, especially as tirzepatide can weaken the pill. Take a test, and see a doctor for heavy, prolonged or unusual bleeding.
Can GLP-1 medicines change your period?
Some people notice their cycle behaving differently after starting semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound): a late period, a heavier one, spotting between periods, or cycles that suddenly become regular. What does the evidence say?
The labels: the current US prescribing information for all four medicines doesn’t list menstrual changes among side effects. Animal studies did see longer reproductive cycles in female rats, which the labels attribute to the drugs’ effect on food intake and body weight.
Safety reports: a 2026 analysis of the FDA’s adverse event reporting system found that some menstrual problems were reported more often than expected. For semaglutide these included heavy bleeding, bleeding between periods, clots and infrequent periods. For tirzepatide, they included bleeding between periods and clots. A second analysis found gynecological bleeding in about 0.6% of reports from women for both medicines, with no difference between them.
Voluntary reports like these can’t show that a drug causes a problem or how often it happens. They’re a reason to take changes seriously and get them checked, not proof.
Why might your cycle change on a GLP-1?
Several things change at once when you start one of these medicines, and any of them can affect your period.
Weight loss and ovulation
Higher weight and insulin resistance can disrupt ovulation, particularly in polycystic ovary syndrome. In PCOS trials, GLP-1 medicines were linked to more regular cycles and more natural pregnancies. If your periods used to be irregular, they may settle, and fertility can return. Our guide to GLP-1 for PCOS covers that evidence.
Eating too little
The opposite can happen too. The Endocrine Society notes that ovulation can stop when the body is under strain from weight loss, stress or heavy exercise. This hasn’t been studied specifically with GLP-1 medicines. Still, a suppressed appetite makes very low intake easy, so if periods stop, mention how much you’re eating. Our guide on what to eat on a GLP-1 helps you make small meals count.
Contraception and other hormones
Tirzepatide slows stomach emptying and can make birth control pills less effective for 4 weeks after starting and after each dose increase. Vomiting or diarrhea soon after taking a pill raises its own questions. Rather than repeat the details here, see our GLP-1 birth control and pregnancy guide. If you take an oral progestogen for heavy periods or as part of hormone therapy, a 2026 review called an effect from tirzepatide plausible but untested. Tell your prescriber.
Life stage and other causes
The NHS lists significant weight change, stress, hormonal contraception and thyroid problems among causes of irregular periods. In perimenopause, periods can come more or less often and be heavier or lighter. Our GLP-1 and menopause guide explains that stage.
Is a late period on Zepbound or Mounjaro a sign of pregnancy?
It can be, so rule pregnancy out first. Two things can raise the odds on tirzepatide: ovulation may return as you lose weight, and the pill may be less reliable during the 4-week windows. Take a pregnancy test. If it’s positive, contact your prescriber and OB-GYN promptly. The Zepbound and Wegovy labels say to stop the medicine once pregnancy is recognized if it’s being used for weight loss.
What counts as a period change worth noting?
The NHS describes heavy periods as needing to change a pad or tampon every 1 to 2 hours, using two products at once, bleeding for more than 7 days, passing clots larger than about 2.5 cm, or bleeding through to clothes or bedding. Feeling tired or short of breath with heavy periods is worth mentioning too.
How do you track your cycle alongside your doses?
A short log makes it far easier to tell whether a change lines up with starting the medicine, a dose increase, or something else. Note:
- the first day of each period and roughly how heavy it is
- spotting or bleeding between periods
- the dates of dose increases and any missed doses
- days with vomiting or diarrhea, if you take the pill
- symptoms such as cramps, fatigue or dizziness
GLPMate doesn’t have a dedicated cycle tracker, but its daily Journal lets you add a mood and a short note each day, and the side-effect log records symptoms with severity next to your dose history. The doctor report then brings it all to your appointment.
What should you ask your doctor?
- Could this be pregnancy, and is my current contraception reliable on this medicine?
- Should we check for anemia or thyroid problems?
- Is my intake enough, given how little appetite I have?
- If I take hormones, could the medicine affect how they work?
When should you see a doctor about period changes?
See your doctor if you have:
- a positive pregnancy test, or a missed period when pregnancy is possible
- heavy bleeding as described above, or bleeding that leaves you tired or short of breath
- periods lasting more than 7 days, or a clear change from your usual pattern
- bleeding between periods or after sex
- any bleeding 12 months or more after your last period
Get urgent care for very heavy bleeding with dizziness or fainting, or severe abdominal or pelvic pain, especially with a positive pregnancy test. Don’t stop or change your dose on your own; your prescriber can look at the medicine alongside other possible causes.
The bottom line
Period changes aren’t a listed side effect of GLP-1 medicines, but they do appear in FDA safety reports, and weight loss can shift cycles, so they deserve attention. Rule out pregnancy first, especially on tirzepatide with the pill. Track what you notice, and bring the pattern to your doctor rather than guessing.
This article is educational only and not medical advice. Talk to your doctor or gynecologist about any change in your periods.
FAQ
Can Ozempic or Wegovy mess up your period?
Period changes aren't listed as a side effect on the US semaglutide labels, but FDA safety reports include heavy, irregular and infrequent bleeding, and weight loss itself can shift cycles. Reports like these can't prove the medicine is the cause. If your pattern changes noticeably, note the dates and talk to your doctor.
Why is my period late on Mounjaro or Zepbound?
Weight loss, eating much less, stress and perimenopause can all delay a period, but pregnancy is the first thing to rule out. Tirzepatide can make birth control pills less effective for 4 weeks after starting and after each dose increase, and better ovulation with weight loss may raise the chance of pregnancy. Take a pregnancy test and contact your prescriber if it's positive.
Can Mounjaro cause heavy periods?
Heavy bleeding isn't listed on the Mounjaro or Zepbound labels. Analyses of FDA safety reports found clots and bleeding between periods reported more often than expected with tirzepatide, but voluntary reports can't show cause or how common it is. Changing a pad or tampon every 1–2 hours, periods over 7 days or large clots are reasons to see a doctor.
Should I stop my GLP-1 if my period changes?
Don't stop or change your dose on your own. Talk to your prescriber, who can check for pregnancy, thyroid problems, anemia or other causes and decide whether the medicine plays a role. Get urgent care for very heavy bleeding with dizziness, or severe pelvic pain.
Sources
- Ozempic, Wegovy, Mounjaro and Zepbound US Prescribing Information — DailyMed, 2026 — no menstrual adverse reactions listed; longer estrous cycles in female rats attributed to reduced food intake and body weight (13.1); tirzepatide may reduce oral contraceptive efficacy (7.2, 8.3); stop when pregnancy is recognized if used for weight reduction (8.1)
- Frey and Etminan, Obstetrics & Gynecology 2026 — GLP-1 receptor agonists and menstrual events, FDA Adverse Event Reporting System analysis — disproportionate reports of heavy menstrual bleeding, intermenstrual bleeding, clots, infrequent periods and anovulatory cycles with semaglutide; intermenstrual bleeding and clots with tirzepatide; no signal with liraglutide
- Makkena, Cureus 2026 — gynecological hemorrhage reports with tirzepatide vs semaglutide (FAERS 2022–2025) — gynecological bleeding in about 0.6% of female reports for both drugs; no difference between them; mostly consumer reports for tirzepatide
- Gordon et al., J Clin Endocrinol Metab 2017 — Functional Hypothalamic Amenorrhea: Endocrine Society Clinical Practice Guideline — loss of ovulation often linked to stress, weight loss, excessive exercise or a combination
- Zhou et al., BMC Endocrine Disorders 2023 — meta-analysis of 11 RCTs (840 women with PCOS) — GLP-1 receptor agonists linked to more regular menstrual cycles and a higher natural pregnancy rate
- Viana et al., Maturitas 2026 — tirzepatide and oral progestogens, hypothesis-generating review — effect of tirzepatide on oral progestogens used for gynecologic conditions or menopause care is plausible but untested
- NHS — Irregular periods and Heavy periods (accessed October 2026) — irregular if the gap is under 21 or over 35 days; causes include significant weight loss or gain, stress, contraception and thyroid problems; heavy-bleeding signs such as changing protection every 1–2 hours, periods over 7 days or clots over 2.5 cm
- NHS — Menopause and perimenopause symptoms (accessed October 2026) — periods may become more or less frequent and heavier or lighter in perimenopause; any bleeding 12 months after the last period should be checked
Sources checked:
This article is educational and is not medical advice, diagnosis or treatment. Medication decisions — including dose changes and what to do after a missed dose — belong with your prescriber. If you experience severe symptoms, seek medical care.